Guidant To Retrain Staff In Response To FDA Inspection
This article was originally published in The Gray Sheet
Executive Summary
Guidant will retrain internal quality systems auditors at all of its cardiac rhythm management device manufacturing sites, including in Puerto Rico and Ireland, the company says in its response to a Form 483 issued by FDA last month
You may also be interested in...
Guidant Shareholders To Vote On J&J Offer; Boston Scientific Still Interested
Guidant's board of directors has formally endorsed Johnson & Johnson's $21.5 bil. takeover bid while simultaneously agreeing to enter into discussions with Boston Scientific on its $25 bil. competing offer
Guidant Shareholders To Vote On J&J Offer; Boston Scientific Still Interested
Guidant's board of directors has formally endorsed Johnson & Johnson's $21.5 bil. takeover bid while simultaneously agreeing to enter into discussions with Boston Scientific on its $25 bil. competing offer
Guidant Posts CRM Performance Data As Stakeholders Discuss Recall Notices
Guidant is providing its 2005 Product Performance Report on its website as part of an effort to improve patient and physician access to device performance information, following a recent string of safety alerts